Does HPV testing have a role in primary cervical screening?

Cytopathology

Volumn 12, Issue 2, 2001, Pages 71-74

  Herrington, C S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSKARYOSIS; EDITORIAL; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MASS SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS DIAGNOSIS; WART VIRUS;

AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DISEASES;

EID: 0035047840     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2001.00311.x     Document Type: Editorial

References (10)

1. Human papillomavirus testing for primary cervical cancer screening
2. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology
3. A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening programme
4. A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening programme: Summary and conclusions
5. Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening
6. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
7. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
8. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN II in women with normal cytology and borderline changes
9. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
10. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears